Verastem Oncology, Inc. (NASDAQ: VSTM) has added another regulatory milestone for VS 7375, a drug still in early testing but now carrying a second Fast...
FDA Fast Track
It is not a household name, but Coya Therapeutics, Inc. (NASDAQ: COYA) sits in the middle of a growing effort to treat neurodegenerative and autoimmune...
